Sugi Predict

Sugi Predict / Compounds / SCHEMBL1753732

SCHEMBL1753732

SCHEMBL1753732

Cc1ccc(N(c2ccc(C)cc2)c2c3ccccc3c(-c3cc(C)cc(-c4c5ccccc5c(N(c5ccc(C)cc5)c5ccc(C)cc5)c5ccccc45)c3)c3ccccc23)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 4/20 0.35
▸ ALDH1A1 P00352 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2A6 P11509 1/20 0.32
▸ BRD9 Q9H8M2 1/20 0.32
▸ BRD7 Q9NPI1 1/20 0.32
▸ MAOB P27338 2/20 0.31
▸ TNKS O95271 1/20 0.31
▸ PARP1 P09874 1/20 0.31
▸ TNKS2 Q9H2K2 1/20 0.31
▸ PARP2 Q9UGN5 1/20 0.31
▸ CTSV O60911 1/20 0.31
▸ CTSL P07711 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13222601 0.96 ACHE (0.37) ACHEALDH1A1TSHRCYP2C19MAOB
SCHEMBL14181740 0.94 ACHE (0.38) ACHEALDH1A1MAOBTNKSPARP1
SCHEMBL1753829 0.93 ACHE (0.33) ACHEALDH1A1TSHRCYP2C19CYP1A2
SCHEMBL14181734 0.92 ACHE (0.38) ACHEALDH1A1CYP2C19CYP1A2HPGD
SCHEMBL14181735 0.92 ACHE (0.38) ACHEALDH1A1CYP2C19CYP1A2HPGD
SCHEMBL13222563 0.92 ACHE (0.37) ACHEALDH1A1TSHRCYP2C19MAOB
SCHEMBL14577020 0.92 ACHE (0.41) ACHEALDH1A1TSHRCYP2C19MAOB
SCHEMBL14181763 0.92 ACHE (0.34) ACHEALDH1A1TSHRCYP2C19MAOB
SCHEMBL13222573 0.91 ACHE (0.35) ACHEALDH1A1CYP2C19CYP1A2HPGD
SCHEMBL13222621 0.89 ACHE (0.44) ACHEALDH1A1TSHRCYP2C19NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210305532-A1 ELECTRONIC DEVICE, MANUFACTURING METHOD OF THE SAME, ELECTRONIC APPARATUS, AND MOVING BODY CANON KABUSHIKI KAISHA (JP) 2021-09-30 — — US disclosed
US-8404363-B2 Organic light emitting device CANON KABUSHIKI KAISHA (JP) 2013-03-26 — — US disclosed
US-8404363-B2 Organic light emitting device CANON KABUSHIKI KAISHA (JP) 2013-03-26 — — US disclosed
US-8354788-B2 Organic light emitting device CANON KABUSHIKI KAISHA (JP) 2013-01-15 — — US disclosed
US-8354788-B2 Organic light emitting device CANON KABUSHIKI KAISHA (JP) 2013-01-15 — — US disclosed
US-20120168739-A1 FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE CANON KABUSHIKI KAISHA (JP) 2012-07-05 — — US disclosed
US-20120168739-A1 FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE CANON KABUSHIKI KAISHA (JP) 2012-07-05 — — US disclosed
US-8158835-B2 Fluorene compound and organic electroluminescence device CANON KABUSHIKI KAISHA (JP) 2012-04-17 — — US disclosed
US-8158835-B2 Fluorene compound and organic electroluminescence device CANON KABUSHIKI KAISHA (JP) 2012-04-17 — — US disclosed
US-20110089822-A1 ORGANIC LIGHT EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2011-04-21 — — US disclosed
US-20090200919-A1 FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE CANON KABUSHIKI KAISHA (JP) 2009-08-13 — — US disclosed
US-20090200919-A1 FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE CANON KABUSHIKI KAISHA (JP) 2009-08-13 — — US disclosed
US-7491450-B2 Organic electroluminescent device CANON KABUSHIKI KAISHA (JP) 2009-02-17 — — US disclosed
US-7491450-B2 Organic electroluminescent device CANON KABUSHIKI KAISHA (JP) 2009-02-17 — — US disclosed
US-7375250-B2 Aminoanthryl derivative substitution compound and organic electroluminescence device using the same CANON KABUSHIKI KAISHA (JP) 2008-05-20 — — US disclosed
US-7375250-B2 Aminoanthryl derivative substitution compound and organic electroluminescence device using the same CANON KABUSHIKI KAISHA (JP) 2008-05-20 — — US disclosed
US-7309533-B2 Substituted anthryl derivative and electroluminescence device using the same CANON KABUSHIKI KAISHA (JP) 2007-12-18 — — US disclosed
US-7309533-B2 Substituted anthryl derivative and electroluminescence device using the same CANON KABUSHIKI KAISHA (JP) 2007-12-18 — — US disclosed
US-7173131-B2 Anthryl derivative group substituted compound, and organic luminescent device making use of same CANON KABUSHIKI KAISHA (JP) 2007-02-06 — — US disclosed
US-7173131-B2 Anthryl derivative group substituted compound, and organic luminescent device making use of same CANON KABUSHIKI KAISHA (JP) 2007-02-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120168739-A1 FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE AFF1, LEF1, AFF2 ACHE 1093/4885ALDH1A1 391/4885TSHR 1706/4885
US-20090200919-A1 FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE AFF1, LEF1, AFF2 ACHE 1093/4885ALDH1A1 391/4885TSHR 1706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.